Genetic test could tailor heart medication, aiming to prevent future heart attacks
NCT ID NCT03783351
Summary
This study is testing if using a genetic test to choose between two common blood-thinning drugs is better for patients who get a heart stent. About 4,000 participants who received a stent for a heart condition will be assigned to either get a drug based on their genetics or based on standard doctor's choice. The goal is to see if the genetic approach leads to fewer heart attacks, strokes, or deaths over one year while also being safe.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Anzhen Hospital
Beijing, Beijing Municipality, 100029, China
-
Beijing Chaoyang Hospital
Beijing, Beijing Municipality, 100000, China
-
Beijing Friendship Hospital
Beijing, Beijing Municipality, 100050, China
-
Beijing LuHe Hospital
Beijing, Beijing Municipality, 101199, China
-
Beijing Tong Ren Hospital
Beijing, Beijing Municipality, 100730, China
-
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, 102218, China
-
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
-
Fuwai Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100037, China
-
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100032, China
Conditions
Explore the condition pages connected to this study.